spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

 

For further information please contact:

Advertising
Jonathan Smith

Editorial
Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


View the digital version of EPC




 

epc
 
 
Featured in this issue
DATA MANAGEMENT
Uniform Data

One for All


To create a complete picture of the drug development world, clinical trial management system data should be collated to enable a common data-sharing platform between businesses, say DrugDev’s Claire Sears and Graeme Benson.
Interview
Industry Insight: Data Monitoring

Quality and Quantity


Marc Buyse at CluePoints tells EPC that monitoring improvements and significant expenses do not need to go hand-in-hand.
  Research and Development
Engineered Nanotechnology

Nano Debate: Part 2


Although we are exposed to nanoparticles through natural sources and in everyday products, they have been shown to damage human health and the environment. Shelley Bowers at Asons Solicitors suggests halting use of engineered nanotechnology until further research is carried out.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December

Banner of COW.EPC on Samedan
Banner of CIC.EPC on Samedan
 
Industry Events

Parallel Trade

9-10 February 2015, Holiday Inn Regents Park Hotel, London, UK

Different regulatory regimes for pharmaceuticals result in significant differences in pharmaceutical prices across countries. These prices make it profitable for parallel trade to take place in addition to it reaching a significant proportion of total national pharmaceutical expenditure in many European countries.
More info >>

 
News and Press Releases

Great Success for the First European Edition of The Dieline Summit

Launched jointly by the international EMBALLAGE exhibition (Comexposium) and THE DIELINE.COM, the first edition of "The Dieline Summit" was held at the Palais des Congrès in Paris on the 16th and 17th November.
More info >>

air transport logo

 

White Papers

Points to Consider When Developing a TMF (Trial Master File) Strategy

Phlexglobal Ltd

Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation. The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems. As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement